Cargando…
Promotion of tumor development in prostate cancer by progerin
Progerin is a truncated form of lamin A. It is identified in patients with Hutchinson-Gilford progeria syndrome (HGPS), a disease characterized by accelerated aging. The contribution of progerin toward aging has been shown to be related to increased DNA damages. Since aging is one major risk factor...
Autores principales: | Tang, Yong, Chen, Yakun, Jiang, Hongmei, Nie, Daotai |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003644/ https://www.ncbi.nlm.nih.gov/pubmed/21106101 http://dx.doi.org/10.1186/1475-2867-10-47 |
Ejemplares similares
-
Interaction of pregnane X receptor with hypoxia-inducible factor-1 regulates chemoresistance of prostate cancer cells
por: Wang, Jiuhui, et al.
Publicado: (2023) -
Progerin guilty of size discrimination
por: Leslie, Mitch
Publicado: (2013) -
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
por: Zhu, Jialin, et al.
Publicado: (2020) -
ZMIZ2 promotes the development of triple-receptor negative breast cancer
por: Zou, Xiaopan, et al.
Publicado: (2022) -
Tumor-suppressing 15-Lipoxygenase-2: Time for prime time?
por: Guo, Yande, et al.
Publicado: (2014)